These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9267686)

  • 1. Pharmacokinetics and multiple peaking of acebutolol enantiomers in rats.
    Piquette-Miller M; Jamali F
    Biopharm Drug Dispos; 1997 Aug; 18(6):543-56. PubMed ID: 9267686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of cimetidine co-administration on the pharmacokinetics of acebutolol enantiomers and its metabolite diacetolol in a rat model: the effect of gastric pH on double-peak phenomena.
    Mostafavi SA; Foster RT
    Int J Pharm; 2003 Apr; 255(1-2):81-6. PubMed ID: 12672604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of single oral and multiple intravenous and oral administration of acebutolol enantiomers in a rat model.
    Mostafavi SA; Foster RT
    Biopharm Drug Dispos; 1998 Oct; 19(7):425-31. PubMed ID: 9818708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of acebutolol enantiomers after intravenous administration of racemate in a rat model: a dosing range comparison.
    Mostafavi SA; Foster RT
    Biopharm Drug Dispos; 1997 Jul; 18(5):397-408. PubMed ID: 9210978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adjuvant arthritis on the disposition of acebutolol enantiomers in rats.
    Piquette-Miller M; Jamali F
    Agents Actions; 1992 Nov; 37(3-4):290-6. PubMed ID: 1295378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of acebutolol enantiomers in humans.
    Piquette-Miller M; Foster RT; Kappagoda CT; Jamali F
    J Pharm Sci; 1991 Apr; 80(4):313-6. PubMed ID: 1865329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an interaction between the beta-blocker pafenolol and bile salts in the intestinal lumen of the rat leading to dose-dependent oral absorption and double peaks in the plasma concentration-time profile.
    Lennernäs H; Regårdh CG
    Pharm Res; 1993 Jun; 10(6):879-83. PubMed ID: 8100633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure.
    Choi JS; Burm JP
    Arch Pharm Res; 2002 Aug; 25(4):541-5. PubMed ID: 12214869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aging on the pharmacokinetics of acebutolol enantiomers.
    Piquette-Miller M; Foster RT; Kappagoda CT; Jamali F
    J Clin Pharmacol; 1992 Feb; 32(2):148-56. PubMed ID: 1613125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo.
    Wetterich U; Spahn-Langguth H; Mutschler E; Terhaag B; Rösch W; Langguth P
    Pharm Res; 1996 Apr; 13(4):514-22. PubMed ID: 8710739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using supported liquid extraction together with cellobiohydrolase chiral stationary phases-based liquid chromatography with tandem mass spectrometry for enantioselective determination of acebutolol and its active metabolite diacetolol in spiked human plasma.
    Jiang H; Randlett C; Junga H; Jiang X; Ji QC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):173-80. PubMed ID: 19109073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presystemic elimination of the beta-blocker pafenolol in the rat after oral and intraperitoneal administration and identification of a main metabolite in both rats and humans.
    Lennernäs H; Renberg L; Hoffmann KJ; Regårdh CG
    Drug Metab Dispos; 1993; 21(3):435-40. PubMed ID: 8100498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective pharmacokinetics of bisoprolol after intravenous and oral administration in beagle dogs.
    Horikiri Y; Suzuki T; Mizobe M
    J Pharm Sci; 1997 May; 86(5):560-4. PubMed ID: 9145379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent intestinal absorption and significant intestinal excretion (exsorption) of the beta-blocker pafenolol in the rat.
    Lennernäs H; Regårdh CG
    Pharm Res; 1993 May; 10(5):727-31. PubMed ID: 8100631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the route of administration on the pharmacokinetics of pirprofen enantiomers in the rat.
    Brocks DR; Liang WT; Jamali F
    Chirality; 1993; 5(2):61-4. PubMed ID: 8343343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of grapefruit juice on the pharmacokinetics of acebutolol.
    Lilja JJ; Raaska K; Neuvonen PJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):659-63. PubMed ID: 16305592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
    Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat.
    Suttle AB; Brouwer KL
    Drug Metab Dispos; 1994; 22(2):224-32. PubMed ID: 8013278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of nebivolol in the rat: low oral absorption, loss in the gut and systemic stereoselectivity.
    Sanaee F; Valente Neves D; Lanchote VL; Jamali F
    Biopharm Drug Dispos; 2013 Sep; 34(6):312-20. PubMed ID: 23625744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucosamine modulates propranolol pharmacokinetics via intestinal permeability in rats.
    Al Shaker HA; Qinna NA; Badr M; Al Omari MMH; Idkaidek N; Matalka KZ; Badwan AA
    Eur J Pharm Sci; 2017 Jul; 105():137-143. PubMed ID: 28502673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.